Sunshine Biopharma
SBFM
Sunshine Biopharma (SBFM) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Aegis Capital | Maintained | Buy | $7.00 | Oct 8, 2025 |
| Aegis Capital | Maintained | Buy | $15.00 | Dec 5, 2024 |
| Aegis Capital | Initiated Coverage | Buy | $2.60 | Aug 7, 2023 |
Frequently asked questions
What is the latest analyst rating on SBFM?
On Oct 8, 2025, Aegis Capital maintained Sunshine Biopharma at Buy with a price target of $7.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.